Monocytes in coronary artery disease and atherosclerosis: where are we now?

A Ghattas, HR Griffiths, A Devitt, GYH Lip… - Journal of the American …, 2013 - jacc.org
Despite improvements in interventional and pharmacological therapy of atherosclerotic
disease, it is still the leading cause of death in the developed world. Hence, there is a need …

Adult bone marrow cell therapy improves survival and induces long-term improvement in cardiac parameters: a systematic review and meta-analysis

V Jeevanantham, M Butler, A Saad, A Abdel-Latif… - Circulation, 2012 - Am Heart Assoc
Background—Despite rapid clinical translation and widespread enthusiasm, the therapeutic
benefits of adult bone marrow cell (BMC) transplantation in patients with ischemic heart …

Stem cell therapy: a new therapeutic option for cardiovascular diseases

NH Goradel, FG Hour, B Negahdari… - Journal of cellular …, 2018 - Wiley Online Library
Cardiovascular diseases are known as one of major causes of morbidity and mortality
worldwide. Despite the many advancement in therapies are associated with cardiovascular …

Adult bone marrow cell therapy for ischemic heart disease: evidence and insights from randomized controlled trials

MR Afzal, A Samanta, ZI Shah… - Circulation …, 2015 - Am Heart Assoc
Rationale: Notwithstanding the uncertainties about the outcomes of bone marrow cell (BMC)
therapy for heart repair, further insights are critically needed to improve this promising …

Transplantation of adipose tissue and stem cells: role in metabolism and disease

TT Tran, CR Kahn - Nature Reviews Endocrinology, 2010 - nature.com
Humans and other mammals have three main adipose tissue depots: visceral white adipose
tissue, subcutaneous white adipose tissue and brown adipose tissue, each of which …

Effects of Intracoronary CD34+ Stem Cell Transplantation in Nonischemic Dilated Cardiomyopathy Patients: 5-Year Follow-Up

B Vrtovec, G Poglajen, L Lezaic, M Sever… - Circulation …, 2013 - Am Heart Assoc
Rationale: CD34+ transplantation in dilated cardiomyopathy was associated with short-term
improvement in left ventricular ejection fraction and exercise tolerance. Objective: We …

Postischemic revascularization: from cellular and molecular mechanisms to clinical applications

JS Silvestre, DM Smadja, BI Levy - Physiological reviews, 2013 - journals.physiology.org
After the onset of ischemia, cardiac or skeletal muscle undergoes a continuum of molecular,
cellular, and extracellular responses that determine the function and the remodeling of the …

Intracoronary autologous cardiac progenitor cell transfer in patients with hypoplastic left heart syndrome: the TICAP prospective phase 1 controlled trial

S Ishigami, S Ohtsuki, S Tarui, D Ousaka… - Circulation …, 2015 - Am Heart Assoc
Rationale: Hypoplastic left heart syndrome (HLHS) remains a lethal congenital cardiac
defect. Recent studies have suggested that intracoronary administration of autologous …

Stem cell treatment for acute myocardial infarction

SA Fisher, H Zhang, C Doree, A Mathur… - Cochrane Database …, 2015 - cochranelibrary.com
Background Cell transplantation offers a potential therapeutic approach to the repair and
regeneration of damaged vascular and cardiac tissue after acute myocardial infarction (AMI) …

Endothelial progenitor cells: novel biomarker and promising cell therapy for cardiovascular disease

S Sen, SP McDonald, PTH Coates… - Clinical science, 2011 - portlandpress.com
Bone-marrow-derived EPCs (endothelial progenitor cells) play an integral role in the
regulation and protection of the endothelium, as well as new vessel formation. Peripheral …